Efila Liver Support
- $88.00$72.00
Efila Liver Support is a 100% health supplement manufactured using Longrunn Medical Technologies' proprietary technology. Efila Liver Support key ingredients is Efila (patented in 2022), the world’s first successfully cultivated strains developed by the company in the formulation of our product.
Out Of Stock!
This product is temporarily out of stock. You may opt-in our waiting list and we'll notify you once the product is restocked.
Product Info
1) Main Benefits
Relieve liver burden and restore metabolic vitality.
EFILA Liver Support is a nutritional jelly designed specifically to support and protect liver function. It is ideal for individuals who frequently consume alcohol, stay up late, have elevated liver enzyme levels, or are at risk of fatty liver. Its core EFILA® ingredient works in synergy with milk thistle extract to accelerate liver cell regeneration, enhance detoxification capacity, and effectively relieve hangover symptoms. This product is suitable for daily liver maintenance and as protective support before drinking alcohol.
Milk thistle, rich in silymarin, has long been used in the adjunct treatment of liver diseases for its anti-inflammatory, antioxidant, and hepatocyte membrane-stabilizing properties. EFILA® itself helps delay liver fibrosis progression and enhance overall metabolic function, making it an ideal liver care solution for individuals under high-stress modern lifestyles.
Key benefits:
- Enhances liver function and promotes hepatocyte regeneration
- Reduces liver inflammation and fibrosis, helps prevent fatty liver
- Alleviates hangover symptoms and protects the liver from alcohol-related damage
2) Recommended For
- Individuals who frequently drink alcohol or wish to support liver health
- Those with abnormal liver enzyme levels or at risk of developing fatty liver
3) Key Ingredients & Functions
- EFILA®(β-glucans, EPS, DMC, and trace elements): A patented multifunctional active ingredient developed from Ceriporia lacerata K1 mycelial fermentation. EFILA® is rich in β-glucans, EPS (exopolysaccharides), DMC, and various trace bioactive compounds. Together, these form a natural nutritional system for liver protection and function repair.
Research shows that EFILA®’s EPS promotes hepatocyte repair and regeneration, suppresses inflammatory responses, and boosts liver enzyme activity—making it beneficial for individuals with chronic fatigue-related liver issues, fatty liver, or elevated ALT/AST levels. DMC, widely recognized in the medical field, provides antioxidant, anti-diabetic, and liver-supportive effects, helping to restore hepatic metabolic capacity at the cellular level.
EFILA® also shows distinct advantages in preventing and relieving alcohol-induced hangovers. Its polysaccharides and flavonoids help neutralize harmful free radicals and acetaldehyde generated during alcohol metabolism, while enhancing NAD+ synthesis in the liver to accelerate alcohol breakdown. EFILA® supports liver alcohol tolerance, reducing typical hangover symptoms such as fatigue, headache, and dry mouth. Long-term use may enhance the liver's resilience to alcohol and reduce the risk of chronic liver damage from repeated alcohol exposure.
- Milk Thistle (Silymarin): A natural compound widely used in liver therapy. It stabilizes liver cell membranes, prevents toxins from entering hepatocytes, promotes protein synthesis, and accelerates liver tissue repair—providing excellent protective and detoxifying effects.
4) Dosage
- For daily liver care: Take 1 jelly 3 times a day, preferably 10–20 minutes before meals.
- For alcohol protection: Take 1 jelly before drinking to reduce alcohol-related liver damage and alleviate hangover severity.
5)Regulatory Recognition
The core EFILA® ingredient — Submerged culture of Ceriporia lacerata mycelium — has been officially recognized by the Singapore Health Sciences Authority (HSA) under the Voluntary Notification System (VNS) as a functional and safe active ingredient for use in Health Supplements and Traditional Medicines.
(VNS Number: VNS-2025-07-00175)
